<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/fda-injunction-supplement-manufacturer-enforcement-action</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-11T14:10:50.161Z</news:publication_date>
      <news:title>FDA Secures Court Injunction Against Supplement Maker in Major Enforcement Shift</news:title>
      <news:keywords>FDA enforcement, injunction, CGMP violations, regulatory compliance, supplement safety</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/biohaven-fda-partial-clinical-hold-epilepsy-drug-safety</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-10T14:10:48.996Z</news:publication_date>
      <news:title>Biohaven Hit with Partial Clinical Hold on Epilepsy Drug Candidate</news:title>
      <news:keywords>FDA, clinical-hold, epilepsy, biohaven, drug-safety</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/bristol-myers-squibb-positive-registrational-trial-results</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-10T08:47:02.319Z</news:publication_date>
      <news:title>Bristol Myers Squibb Achieves Positive Trial Results Amid Industry Headwinds</news:title>
      <news:keywords>clinical trials, drug development, Bristol Myers Squibb, regulatory approval, pharmaceutical research</news:keywords>
    </news:news>
  </url>
</urlset>